The Valley Desk

ArticleAnnals of the rheumatic diseasesPublished

Thresholds for efficacy outcomes in psoriatic arthritis vary according to baseline disease activity but not according to prior tumour necrosis factor inhibitor treatment

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Johnson & Johnson, Perelman School of Medicine, with University of Pennsylvania linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
Annals of the rheumatic diseases
Published
Subject terms
Humans; Arthritis, Psoriatic; Tumor Necrosis Factor-alpha; Antirheumatic Agents; Treatment Outcome; Severity of Illness Index; Adult; Middle Aged; Female; Male; Randomized Controlled Trials as Topic; Antibodies, Monoclonal, Humanized
PubMed ID
42128704
Added to directory
Source checked

Report a correction or request removal